By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Allergan plc 

U.S. Administrative Headquarters
Morris Corporate Center III, 400 Interpace Parkway
Parsippany  New Jersey  07054  U.S.A.
Phone: 862-261-7000 Fax: n/a


SEARCH JOBS

Allergan plc (AGN), headquartered in Dublin, Ireland, is a unique, global pharmaceutical company and a leader in a new industry model – Growth Pharma. Allergan is focused on developing, manufacturing and commercializing innovative branded pharmaceuticals, high-quality generic and over-the-counter medicines and biologic products for patients around the world.

Allergan markets a portfolio of best-in-class products that provide valuable treatments for the central nervous system, eye care, medical aesthetics, gastroenterology, women's health, urology, cardiovascular and anti-infective therapeutic categories, and operates the world's third-largest global generics business, providing patients around the globe with increased access to affordable, high-quality medicines. Allergan is an industry leader in research and development, with one of the broadest development pipelines in the pharmaceutical industry.

We’re Looking for the World’s Best

At Allergan, we are committed to recruiting and retaining the industry’s best and brightest employees and are proud to offer opportunities for military veterans at all levels across our company. We offer business, scientific, technical, engineering, sales & marketing and a variety of other positions here in the U.S. and around the world.

At Allergan, you will find an entrepreneurial style work environment where employees and employee teams are encouraged to apply their unique talents to grow, contribute, innovate and excel. We welcome your ideas. We provide the support, resources and encouragement that enable you to take your career to new heights. We focus on challenging you, challenging ourselves and driving success.

Commit to your future and join us. Learn more about our exciting career opportunities at www.allergan.com/careers.

YEAR FOUNDED:

1948

LEADERSHIP:

Founder: Gavin S. Herbert

CEO: Brenton L. Saunders

CFO: Maria Teresa Hilado

CLINICAL TRIAL:

Please click here for clinical trial information.

PRODUCTS:

All Products

FOLLOW ALLERGAN:




Key Statistics


Email:
Ownership: Public

Web Site: Allergan
Employees:
Symbol: AGN
 



Industry
Pharmaceutical


Collaborations

Elan Pharmaceuticals 

CeNes Pharmaceuticals (U.S.) 

PanVera LLC 

Pharmagene Laboratories Limited  Phase ZERO(TM) products and services.

Acadia  Discovery of alpha adrenergic drug candidates that may represent a significant breakthrough in the treatment of neuropathic pain.

Acadia  Develop and commercialize selective muscarinic drugs for the treatment of glaucoma.

Acadia  The third collaboration is designed to leverage ACADIA's R&D platform to discover and develop new therapeutics predominantly in the area of pain.





Company News
Assembly Biosciences (ASMB) Announces The Closing And Early Termination Of Hart-Scott-Rodino Waiting Period For License Of Microbiome Gastrointestinal Development Programs To Allergan (AGN) 2/21/2017 8:30:28 AM
5 Ways Booming Allergan (AGN) Can Keep Up Momentum 2/16/2017 6:44:43 AM
Valeant (VRX), Pershing Square to Split Legal Costs on Allergan (AGN) Lawsuit 2/15/2017 7:15:40 AM
Medicines360 And Allergan (AGN) Announce Partnership With Health Centers To Help Address Unintended Pregnancies In Areas Impacted By Zika 2/15/2017 6:47:25 AM
Real Life Employees Talk About Working At Allergan (AGN), Seattle Genetics (SGEN) And Shire (SHPG) 2/14/2017 4:41:54 PM
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters 2/14/2017 6:10:10 AM
Deal Spree Continues as Allergan (AGN) Inks $2.47 Billion Deal for This Bay Area Biotech 2/13/2017 6:20:27 AM
Drug Giant Pfizer (PFE) Bounces Back From Allergan (AGN) Setback By Buying, Buying, Buying 2/10/2017 8:39:22 AM
Unlike Many of Its Peers, Allergan (AGN) Beats Forecast and Is on the Hunt for More M&A Deals 2/8/2017 9:16:24 AM
Allergan (AGN) Provides Board And Annual Shareholder Meeting Updates 2/6/2017 9:10:38 AM
12345678910...
//-->